Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zentalis Pharmaceuticals (ZNTL) Return on Sales (2024 - 2025)

Historic Return on Sales for Zentalis Pharmaceuticals (ZNTL) over the last 2 years, with Q3 2025 value amounting to 5.56%.

  • Zentalis Pharmaceuticals' Return on Sales fell 11400.0% to 5.56% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.56%, marking a year-over-year decrease of 11400.0%. This contributed to the annual value of 2.46% for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Zentalis Pharmaceuticals' Return on Sales stood at 5.56%, which was down 11400.0% from 6.06% recorded in Q2 2025.
  • Over the past 5 years, Zentalis Pharmaceuticals' Return on Sales peaked at 0.25% during Q1 2024, and registered a low of 8.34% during Q1 2025.